Firstly, we demonstrated that intratumoral heterogeneity can be a major confounding factor when assessing PD-L1 status in SCCHN: a substantial amount of primary tumor biopsies were found to have discordant CPS compared to their paired resection specimens. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.